Theorem Clinical Research

Awards & Advancement

George A. Scangos to join Agilent Technologies board of directors

Thursday, March 20, 2014 12:00 PM

Agilent Technologies, a measurement and technology company focused on chemical analysis, life sciences, diagnostics, electronics and communications, has announced that George A. Scangos, Ph.D., CEO and director of Biogen Idec, has been appointed to Agilent’s board of directors and will join the board in September.

More... »


CFS Clinical sponsors STEM event

Thursday, March 13, 2014 01:33 PM

Statistics continue to show girls are not embracing careers in technology, despite an increasing need for skilled professionals in STEM (Science, Technology, Engineering and Math) fields in the nation. Girls Exploring Tomorrow’s Technology (GETT) promotes academic achievement in all girls in sixth to twelfth grade in the Delaware Valley and introduces them to the idea of potentially having a future in technology.

More... »


Infinity appoints Baselga, Berkowitz to board of directors

Thursday, March 13, 2014 11:26 AM

Infinity Pharmaceuticals has appointed José Baselga M.D., Ph.D., and Jeff Berkowitz as independent members of its board of directors. Baselga, physician-in-chief at Memorial Sloan-Kettering Cancer Center, is an accomplished clinician and a thought leader in the PI3K field. Berkowitz, as the president of Walgreens Boots Alliance Development in Europe, has experience in pharmaceuticals, pharmacy, distribution and market access, pricing and reimbursement.

More... »

Theorem Clinical Research recognized in 2014 CRO Leadership Awards

Thursday, March 13, 2014 11:10 AM

Theorem Clinical Research has won recognition in all five categories of the 2014 CRO Leadership Awards: Quality, Productivity, Reliability, Innovation and Regulatory.

More... »

Chiltern wins CRO leadership award from Life Science Leader

Friday, March 7, 2014 09:31 AM

Global CRO Chiltern has been recognized with a CRO Leadership Award in all five categories: Quality, Reliability, Productivity, Innovation and Regulatory. The awards are given by Life Science Leaderpublication based on the data-driven research of Nice Insight. Chiltern is the only organization to be recognized in all five categories for three straight years.

More... »

Accelovance nominated for two Vaccine Industry Excellence Awards

Thursday, March 6, 2014 11:49 AM

Accelovance, a therapeutically focused CRO, has been named a finalist for two Vaccine Industry Excellence (ViE) Awards, with nominations for "Best Contract Research Organization" and "Best Clinical Trial Network and Site."

More... »

Minerva Neurosciences expands executive team

Thursday, March 6, 2014 10:30 AM

Minerva Neurosciences, a developer of new therapies to treat neuropsychiatric diseases and disorders, has launched the new company web site (www.minervaneurosciences.com) following the successful transfer of the Minerva Neurosciences corporate headquarters from New Jersey to Cambridge, Mass. The establishment of a new corporate headquarters follows the recent appointment of Rogerio Vivaldi, M.D., MBA, as the new president and CEO, and Marc Beer as the new chairman of the board of directors of Minerva Neurosciences. The company was founded in 2013 by the merger of Cyrenaic Pharmaceuticals and Sonkei Pharmaceuticals.

More... »

Steven W. J. Kent joins CRF Health’s board of directors

Monday, March 3, 2014 09:00 AM

CRF Health, a provider of electronic Clinical Outcome Assessment (eCOA) solutions for global clinical trials, has announced that Steven W. J. Kent, former CEO of ClinPhone and former president of Perceptive Informatics, has joined the company’s board of directors as chairman.

More... »

CluePoints expands global team

Friday, February 28, 2014 11:36 AM

CluePoints, a provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has announced three new appointments to its global team. John Colby and Elizabeth Polvent join the company's U.S business development team, fulfilling a key element in its strategy for growth, while CluePoints also welcomes Jean Stéphenne, president of the board of directors of GlaxoSmithKline Biologicals, as a member of its board.

More... »

Ariad appoints Alexander J. Denner to board of directors

Monday, February 24, 2014 12:26 PM

Ariad Pharmaceuticals, an integrated global oncology company, has appointed Alexander J. Denner, Ph.D., to a two-year term on the company's board of directors, effective immediately. With the addition of Denner, who is the chief investment officer and founding partner of Sarissa Capital Management LP, the board now comprises nine directors, eight of whom are independent. The company also will appoint another independent director to the board, who will be selected by the board and be subject to Denner's concurrence.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 2

Roche's $8.3B InterMune buy continues its buying spree with 'bolt-on' deal, fueling record M&A activity

FDA action plan seeks to close gap in women and minority patient representation in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs